Regeneron Pharmaceuticals, Inc.
REGN · NASDAQ · Healthcare
796.37USD+18.01▲ +2.31%
Prices delayed 15 minutes
Key data
- Market cap
- 74.82B USD
- P/E ratio
- 19.20
- EPS (trailing 12 months)
- 41.48 USD
- Revenue (trailing 12 months)
- 14.34B USD
- Dividend yield
- 0.46%
- Price-to-book
- 2.36
- Beta (volatility)
- 0.49
- Average volume (20 sessions)
- 762.56K
52-week low and high
564.00859.34
Latest news & analysis
No published news about this stock yet.
For information only; not a recommendation to buy or sell. Prices may be delayed up to 15 minutes.